Compare AstraZeneca plc (AZN) vs Brookfield Infrastructure Partners LP (BIP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AstraZeneca plc vs Brookfield Infrastructure Partners LP — how do they compare? AstraZeneca plc trades at $158.1 (market cap $248.14B), while Brookfield Infrastructure Partners LP trades at $39 (market cap $18.10B). The key difference: AstraZeneca plc is far larger — about 13.7× Brookfield Infrastructure Partners LP's market cap, and Brookfield Infrastructure Partners LP pays the higher dividend (4.62%). Which is the better fit depends on your goals.
| AZN | BIP | |
|---|---|---|
Market Cap | $248.14B | $18.10B |
Sector | Health | Industrials |
52-Week High | $209.48 | $42.62 |
52-Week Low | $147.06 | $29.81 |
Enterprise Value | $275.41B | $77.05B |
Dividend Yield | 2.01% | 4.62% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AstraZeneca plc
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →About Brookfield Infrastructure Partners LP
Brookfield Infrastructure owns and operates high-quality global assets across utilities, transport, midstream, and data sectors. It focuses on generating stable, long-term cash flows from essential infrastructure.
Read more on BIP →
